|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities | |||||
| Depreciation and amortization | |||||
| Loss (gain) on disposal of property and equipment | |||||
| Bad debts | |||||
| Goodwill impairment loss | |||||
| Other assets impairment | |||||
| Unrealized gain on equity securities | |||||
| Real estate property under development impairment | |||||
| Changes in assets and liabilities | |||||
| Accounts receivable | |||||
| Net Cash from directors | |||||
| Real estate property under development | |||||
| Customer deposits | |||||
| Amount due from unconsolidated affiliates | |||||
| Other receivables and deposits | |||||
| Accounts payable | |||||
| Other payables and accrued expenses | |||||
| Taxes payable | |||||
| Other Tax payable | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisition of property, plant and equipment | |||||
| Acquisition of investment | |||||
| Transactional financial assets | |||||
| Net cash provided by investing activities | |||||
| Advances from an affiliate | |||||
| Dividends paid | |||||
| Net cash (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of year | |||||
| Cash, cash equivalents, and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Income taxes paid | |||||
| Interest paid | |||||
Loading...